BridgeBio Pharma Inc (BBIO) Insider Trading

Total insider buys:
  • $127,912,608.53
Total insider sells:
  • $386,824,513.53
Most recent insider trade:
  • March 1, 2024
Most active insider trader:
  • Neil Kumar
Trader NameDateTitleAmountPriceTypeTotal Value
March 1, 2024Director2,500$34.00Sell$85,000.00
Jan. 16, 2024Director2,915$37.97Sell$110,682.55
Dec. 26, 2023Director100,000$42.06Sell$4,206,000.00
Dec. 18, 2023Director2,000$40.00Sell$80,000.00
Aug. 17, 2023CEO51,552$28.59Sell$1,473,871.68
Aug. 17, 2023CFO22,683$28.59Sell$648,506.97
July 18, 2023Major Shareholder1,500,000$35.00Sell$52,500,000.00
May 17, 2023CEO51,552$14.01Sell$722,243.52
May 17, 2023CFO24,424$14.01Sell$342,180.24
April 5, 2023CEO120,000$15.46Sell$1,855,200.00
April 5, 2023CFO55,500$15.45Sell$857,475.00
March 3, 2023CFO62,692$10.96Sell$687,104.32
March 3, 2023CEO120,000$10.96Sell$1,315,200.00
Feb. 17, 2023CEO44,798$12.70Sell$568,934.60
Feb. 17, 2023CFO17,717$12.70Sell$225,005.90
Feb. 3, 2023CFO61,040$11.01Sell$672,050.40
Feb. 3, 2023CEO120,000$11.01Sell$1,321,200.00
Jan. 5, 2023CFO61,040$7.67Sell$468,176.80
Jan. 5, 2023CEO120,000$7.67Sell$920,400.00
Nov. 17, 2022CFO19,678$9.40Sell$184,973.20
Nov. 17, 2022CEO34,640$9.40Sell$325,616.00
March 14, 2022Director10,000$8.19Buy$81,900.00
Jan. 4, 2022Director5,000$16.82Buy$84,100.00
Dec. 30, 2021Director10,402$14.34Buy$149,164.68
Dec. 28, 2021Director11,745$12.73Buy$149,513.85
Aug. 4, 2021Insider13,777$53.23Sell$733,349.71
Feb. 17, 2021Director16,000$62.50Buy$1,000,000.00
Feb. 17, 2021Insider8,000$62.50Buy$500,000.00
Feb. 17, 2021Major Shareholder3,450,000$60.47Sell$208,621,500.00
Dec. 28, 2020Insider19,500$69.60Sell$1,357,200.00
Dec. 21, 2020Insider60,401$65.32Sell$3,945,393.32
Dec. 1, 2020Insider10,000$51.52Sell$515,200.00
Nov. 25, 2020Insider742$47.23Sell$35,044.66
Nov. 16, 2020Insider10,000$45.00Sell$450,000.00
Nov. 5, 2020Insider2,500$42.05Sell$105,125.00
Nov. 2, 2020Insider10,000$38.36Sell$383,600.00
Oct. 16, 2020Chairman10,256$41.00Sell$420,496.00
Sept. 30, 2020Insider14,500$37.69Sell$546,505.00
Sept. 29, 2020Chairman18,200$37.50Sell$682,500.00
Sept. 25, 2020Chairman81,057$36.83Sell$2,985,329.31
Sept. 18, 2020Insider2,500$42.01Sell$105,025.00
Sept. 15, 2020Insider2,500$37.06Sell$92,650.00
Aug. 3, 2020Insider4,661$27.27Sell$127,105.47
Aug. 3, 2020CEO66,057$27.27Sell$1,801,374.39
July 1, 2020CEO87,025$31.09Sell$2,705,607.25
June 30, 2020Insider10,000$32.66Sell$326,600.00
June 3, 2020CEO5,930$30.05Sell$178,196.50
June 3, 2020Insider1,600$30.04Sell$48,064.00
May 28, 2020Major Shareholder2,389,690$33.39Sell$79,791,749.10
May 5, 2020CEO79,600$31.02Sell$2,469,192.00
First«1 of 2»Last
  • Insiders are both buying and selling BridgeBio Pharma Inc stock.

  • The insider traders at BridgeBio Pharma Inc are: Neil Kumar, Brian C Stephenson, Cameron Turtle, Michael Thomas Henderson, Genetic Disorder L.P. Kkr, Charles J. Homcy, Frank Mccormick, Randal W Scott, Richard H Scheller, Douglas A Dachille, Charles J Homcy, Global Investors Lp Viking, Ronald J Daniels, Brian C. Stephenson, and Hannah Valantine

  • The most active insider trader at BridgeBio Pharma Inc is Neil Kumar with 16 trades.

  • Genetic Disorder L.P. Kkr has sold the most BridgeBio Pharma Inc stock with a total value of $497,034,749.10.

  • Global Investors Lp Viking has bought the most BridgeBio Pharma Inc stock with a total value of $160,000,600.00.

  • The most recent insider trade for BridgeBio Pharma Inc was on March 1, 2024.

  • The single biggest insider buy for BridgeBio Pharma Inc was from Global Investors Lp Viking with a total value of $80,000,300.00 on June 27, 2019.

  • The single biggest insider sell for BridgeBio Pharma Inc was from Genetic Disorder L.P. Kkr with a total value of $208,621,500.00 on Feb. 17, 2021.